{"transactions":[{"id":2454308,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":131832,"kind":"person","name":"Pennington James","position":1,"cik":"0001668704","reported_name":"Pennington James","relationship":{"officer":true,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock option (right to buy)","published_at":"2022-01-03T21:07:18.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in 36 equal monthly installments over a term of three (3) years beginning on the date of grant, conditioned on Mr. Pennington's continued employment by First Wave BioPharma, Inc. on the applicable vesting date."}],"balance_after":7500,"derivative":{"exercise_price":1.45,"expiration_date":"2032-01-03","underlying":"Common stock, par value $0.0001 per share","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001140361-22-000300","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668704/000114036122000300/form4.xml","form_type":"4"}},{"id":2637036,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":131832,"kind":"person","name":"Pennington James","position":1,"cik":"0001668704","reported_name":"Pennington James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock option (right to buy)","published_at":"2021-07-09T17:11:55.000Z","date":"2021-07-09","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in 36 equal monthly installments over a term of three (3) years beginning on the date of grant, conditioned on Mr. Pennington's continued employment by AzurRx BioPharma, Inc. on the applicable vesting date."}],"balance_after":100000,"derivative":{"exercise_price":0.75,"expiration_date":"2031-07-09","underlying":"Common stock, par value $0.0001 per share","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-21-003573","document":"form4-07092021_020744.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668704/000141588921003573/form4-07092021_020744.xml","form_type":"4"}},{"id":3079575,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":131832,"kind":"person","name":"Pennington James","position":1,"cik":"0001668704","reported_name":"Pennington James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock option (right to buy)","published_at":"2020-07-20T21:54:44.000Z","date":"2020-07-16","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in 36 equal monthly installments over a term of three (3) years beginning on August 16, 2020, conditioned on Mr. Pennington's continued employment by AzurRx BioPharma, Inc. on the applicable vesting date."}],"balance_after":300000,"derivative":{"exercise_price":0.85,"expiration_date":"2030-07-15","underlying":"Common stock, par value $0.0001 per share","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001415889-20-001939","document":"form4-07202020_060736.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668704/000141588920001939/form4-07202020_060736.xml","form_type":"4"}},{"id":3079574,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":131832,"kind":"person","name":"Pennington James","position":1,"cik":"0001668704","reported_name":"Pennington James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock option (right to buy)","published_at":"2020-07-20T21:53:42.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests, if at all, upon the achievement of certain specified performance targets. Vesting is conditioned on Mr. Pennington's continued employment by AzurRx BioPharma, Inc. on the applicable vesting date."}],"balance_after":110000,"derivative":{"exercise_price":1.75,"expiration_date":"2024-06-12","underlying":"Common stock, par value $0.0001 per share","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001415889-20-001938","document":"form4-07202020_060734.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668704/000141588920001938/form4-07202020_060734.xml","form_type":"4"}},{"id":3864550,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":131832,"kind":"person","name":"Pennington James","position":1,"cik":"0001668704","reported_name":"Pennington James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Options","published_at":"2018-07-19T13:20:48.000Z","date":"2018-07-12","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options with respect to 37,500 shares vest upon the acceptance of a U.S. IND for MS 1819, and the remaining 37,500 shares vest upon the the first CF patient dosed with MS1819\nanywhere in the globe."}],"balance_after":75000,"derivative":{"exercise_price":3.04,"expiration_date":"2023-06-28","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001415889-18-001136","document":"form4-07192018_100730.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668704/000141588918001136/form4-07192018_100730.xml","form_type":"4"}}]}